Physician profile
Vance M Thompson
NPI 1073519989
$1,869,119.31
in general payments reported to CMS, 2019-2025
35 companies · $921K in 2025
The $921K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $88K · 2021: $56K · 2022: $224K · 2023: $41K · 2024: $446K · 2025: $921K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.0M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $359K · Food and Beverage: $5,478 · Travel and Lodging: $3,224 · Gift: $36.14 · Honoraria: $25.59 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,040,416.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $359,249.37 |
| Food and Beverage | $5,478.12 |
| Travel and Lodging | $3,223.56 |
| Gift | $36.14 |
| Honoraria | $25.59 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beaver-Visitec International, INC. | $1,110,536.89 | 2020-2025 | Podeye Toric Iol |
| Rxsight INC | $521,494.43 | 2019-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $105,778.81 | 2019-2025 | Tecnis Simplicity, Star S4 Ir, Tecnis Iol |
| Carl Zeiss Meditec, INC. | $33,789.52 | 2019-2025 | Visumax, Mel 90 |
| Glaukos Corporation | $30,410.62 | 2020-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Idose |
| Tearoptix, INC. | $16,500.00 | 2021 | |
| Alcon Vision LLC | $15,557.64 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Centurion |
| Bausch & Lomb Americas INC. | $8,222.38 | 2023-2025 | Crystalens Accommodating Iol (At-52ao), Envista Envy Iol, Envista Mx60 Iol |
| Alcon Research LLC | $5,955.85 | 2019-2025 | |
| Oyster Point Pharma, INC. | $3,284.56 | 2022-2024 | Tyrvaya |
| Leica Microsystems INC. | $2,750.00 | 2020 | |
| Sight Sciences, INC. | $2,459.08 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ocular Therapeutix, INC. | $2,263.51 | 2020-2021 | |
| Allergan, INC. | $1,750.00 | 2020 | |
| Tearlab Corp | $1,719.93 | 2022-2023 | Tearlab Osmolarity System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $1,526.41 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $1,284.91 | 2021-2025 | Visumax, Artevo 800 |
| Lensar, INC. | $1,011.23 | 2021-2025 | Lensar Laser System |
| Shire North American Group INC | $709.19 | 2019 | |
| Rayner Intraocular Lenses Limited | $697.94 | 2022-2024 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Abbvie INC. | $584.83 | 2021-2025 | Durysta |
| Nordic Pharma, INC. | $350.00 | 2025 | Lacrifill |
| Novartis Pharmaceuticals Corporation | $185.44 | 2020-2023 | |
| Lkc Technologies, INC. | $66.67 | 2023 | |
| Mallinckrodt Hospital Products INC. | $62.70 | 2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $43.42 | 2024-2025 | Xdemvy |
| Omeros Corporation | $43.00 | 2021 | |
| Dompe US, INC. | $19.33 | 2022 | |
| Astellas Pharma Global Development | $18.37 | 2024 | Izervay |
| Amgen INC. | $15.70 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $13.92 | 2022 | |
| Carl Zeiss Meditec Cataract Technology INC. | $13.03 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$741,981.83 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$2,638,020.77 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.